project id: TCGA-PAAD; case submitter id: TCGA-2L-AAQM; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.34; rna integrity number: 8.8; age at index: 52; days to birth: -19315; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 19315; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1383.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8246/3; primary diagnosis: Neuroendocrine carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pancreas, NOS; synchronous malignancy: No; tissue or organ of origin: Pancreas, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 1091; days to sample procurement: 0; specimen type: Solid Tissue; percent lymphocyte infiltration: 70.0; percent monocyte infiltration: 10.0; percent necrosis: 0.0; percent neutrophil infiltration: 10.0;